Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
146.9 USD | +1.09% | -0.07% | -6.30% |
May. 31 | Sector Update: Health Care Stocks Higher Late Afternoon | MT |
May. 31 | US lawmakers ask FBI for briefing on GenScript Biotech's links to China | RE |
Financials (USD)
Sales 2024 * | 88.35B | Sales 2025 * | 90.82B | Capitalization | 350B |
---|---|---|---|---|---|
Net income 2024 * | 22.04B | Net income 2025 * | 23.09B | EV / Sales 2024 * | 3.89 x |
Net cash position 2024 * | 6.18B | Net cash position 2025 * | 19.02B | EV / Sales 2025 * | 3.64 x |
P/E ratio 2024 * |
16.1
x | P/E ratio 2025 * |
15.3
x | Employees | 131,900 |
Yield 2024 * |
3.32% | Yield 2025 * |
3.47% | Free-Float | 77.08% |
Latest transcript on Johnson & Johnson
1 day | +1.09% | ||
1 week | -1.90% | ||
Current month | +1.57% | ||
1 month | +1.57% | ||
3 months | -9.41% | ||
6 months | -5.04% | ||
Current year | -6.30% |
Managers | Title | Age | Since |
---|---|---|---|
Joaquin Duato
CEO | Chief Executive Officer | 61 | 88-12-31 |
Joseph Wolk
DFI | Director of Finance/CFO | 57 | 97-12-31 |
James Swanson
CTO | Chief Tech/Sci/R&D Officer | 58 | 19-11-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marillyn Hewson
BRD | Director/Board Member | 70 | 19-04-24 |
D. Davis
BRD | Director/Board Member | 72 | 14-06-18 |
Anne Mulcahy
BRD | Director/Board Member | 70 | 09-10-21 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
14.01% | 254 M€ | +13.69% | - | |
12.91% | 17 M€ | +6.09% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 146.7 | +0.96% | 14,620,727 |
24-05-30 | 145.3 | +0.58% | 8,491,111 |
24-05-29 | 144.4 | +0.04% | 8,263,810 |
24-05-28 | 144.4 | -1.76% | 10,499,829 |
24-05-24 | 147 | -1.82% | 9,520,576 |
Delayed Quote Nyse, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.30% | 350B | |
+40.73% | 734B | |
+32.83% | 591B | |
+15.15% | 315B | |
+4.05% | 276B | |
+15.00% | 238B | |
+9.78% | 206B | |
-5.52% | 204B | |
+6.17% | 161B | |
-0.45% | 160B |
- Stock Market
- Equities
- JNJ Stock